The American Journal of Surgery
Volume 196, Issue 2 , Pages 176-183 , August 2008

Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes

  • Peter Schrenk, M.D.

      Affiliations

    • Second Department of Surgery, Ludwig Boltzmann Institute for Surgical Endoscopy, AKH Linz, Krankenhausstrasse 9, 4020 Linz, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +1143-664-443-3468; fax: +1143-732-78062198.
    • ,
  • Christoph Tausch, M.D.

      Affiliations

    • Second Department of Surgery, Ludwig Boltzmann Institute for Surgical Endoscopy, AKH Linz, Krankenhausstrasse 9, 4020 Linz, Austria
    • ,
  • Soraya Wölfl, M.D.

      Affiliations

    • Department of Pathology, AKH Linz, Austria
    • ,
  • Stephan Bogner, M.D.

      Affiliations

    • Department of Pathology, AKH Linz, Austria
    • ,
  • Michael Fridrik, M.D.

      Affiliations

    • Department of Medical Oncology, AKH Linz, Austria
    • ,
  • Wolfgang Wayand, M.D.

      Affiliations

    • Second Department of Surgery, Ludwig Boltzmann Institute for Surgical Endoscopy, AKH Linz, Krankenhausstrasse 9, 4020 Linz, Austria

Received 18 March 2007 ,Revised 8 August 2007

References 

  1. Powles TJ, Hickish TF, Makris A, et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol. 1995;13:547–552
  2. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483–2493
  3. Vlastos G, Mirza NQ, Lenert JT, et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer. 2000;88:1417–1424
  4. Kuerer HM, Sahin AA, Hunt KK, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72–78
  5. Botti C, Vici P, Lopez M, et al. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg. 1995;181:202–208
  6. Pierga JY, Mouret E, Dieras V, et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer. 2000;83:1480–1487
  7. Weatherall PT, Evans GF, Metzger GJ, et al. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging. 2001;13:868–875
  8. Klauber-DeMore N, Kuzmiak C, Rager E, et al. High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Am J Surg. 2004;188:386–389
  9. Fehr MK, Hornung R, Varga Z, et al. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J. 2004;10:89–93
  10. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with Sentinel lymphadenectomy. Ann Surg. 1995;222:394–401
  11. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–653
  12. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg. 1999;229:528–535
  13. Veronesi U, Galimberti V, Mariani L, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41:231–237
  14. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480–3486
  15. Nason KS, Anderson BO, Byrd DR, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000;89:2187–2194
  16. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2002;184:315–317
  17. Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9:235–242
  18. Kang SH, Kang JH, Choi EA, Lee ES. Sentinel lymph node biopsy after neoadjuvant chemotherapy. Breast Cancer. 2004;11:233–241
  19. Lang JE, Esserman LJ, Ewing CA, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004;199:856–862
  20. Shimazu K, Tamaki Y, Taguchi T, et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy–treated breast carcinoma. Cancer. 2004;100:2555–2561
  21. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results form National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694–2702
  22. Kinoshita T, Takasugi M, Iwamoto E, et al. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg. 2006;191:225–229
  23. Tausch C, Konstantiniuk P, Kugler F, et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel node study group. Ann Surg Oncol. 2007;in press
  24. Yu JC, Hsu GC, Hsieh CB, et al. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol. 2007;14:174–180
  25. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guidline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720
  26. Sabel MS, Schott AF, Kleer CG, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg. 2003;186:102–105
  27. Schrenk P, Hochreiner G, Fridrik M, Wayand W. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J. 2003;4:282–287
  28. Ollila DW, Neuman HB, Sartor C, et al. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg. 2005;190:371–375
  29. Khan A, Sabel MS, Nees A, et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy paients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol. 2005;12:697–704
  30. Jones JL, Zabicki K, Christian RL, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg. 2005;190:517–520
  31. van Rijk MC, Nieweg OE, Rutgers EJ, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006;13:475–479
  32. Cox CE, Cox JM, White LB, et al. Sentinel node biopsy before neoadjuvan chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol. 2006;13:483–490
  33. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel lymph node biopsy for breast cancer—not yet the standard of care. N Engl J Med. 1998;339:990–995
  34. Vigario A, Sapienza MT, Sampaio AP, et al. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin Nucl Med. 2003;28:553–557
  35. Cohen LF, Breslin TM, Kuerer HM, et al. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000;24:1266–1272
  36. Sharkey FE, Addington SL, Fowler LJ, et al. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996;9:893–900
  37. Schrenk P, Tausch C, Wagner E, et al. Follow up lymphatic mapping in patients after previous axillary surgery. Senology. 2006;3:185–193
  38. Wong SL, Edwards MJ, Chao C, et al. The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J. 2002;8:192–198
  39. Bembenek A, Fischer J, Albrecht H, et al. Impact of patient- and disease-specific factors on SLNB in breast cancer patients (Are current guidelines justified?). World J Surg. 2006;31:267–275
  40. Specht MC, Fey JV, Borgen PI, Cody HS. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg. 2005;200:10–14

PII: S0002-9610(08)00246-8

doi: 10.1016/j.amjsurg.2007.08.068

The American Journal of Surgery
Volume 196, Issue 2 , Pages 176-183 , August 2008

Article Tools

* Image Usage & Resolution